Plain-English translation of NCT06544083 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are working to create a new blood test that can detect liver cancer early by looking at specific proteins in your blood. This study will collect blood samples from people with liver cancer, people with benign (non-cancerous) liver conditions, and healthy people to build and test this new screening tool.
Current methods for detecting liver cancer early are not always reliable or easy to use. Developing a simple blood test could help doctors catch liver cancer at earlier, more treatable stages when outcomes are often better.
You likely qualify if…
You likely don't qualify if…
You will have a single blood sample drawn, which researchers will analyze for specific proteins. The study is divided into two phases: first, 200 people will participate at one hospital in China, and then 400 more people will participate across multiple centers. Your regular cancer diagnosis, treatment, and follow-up care will not be affected by this study and will continue as normal.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators
First Affiliated Hospital of Harbin Medical University, Zhongnan Hospital
Enrollment target
~600 participants
Started
February 2024
Primary completion
December 2026
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Weilin Wang
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.